TLDR Hyperliquid is scheduled for a cliff unlock worth $251 million which is the largest among all altcoins this week. SUI, EIGEN, OP, KMNO, ENA, ZORA, and SVL TLDR Hyperliquid is scheduled for a cliff unlock worth $251 million which is the largest among all altcoins this week. SUI, EIGEN, OP, KMNO, ENA, ZORA, and SVL

Token Unlock Countdown: Will These Altcoins Crash Under Pressure?

TLDR

  • Hyperliquid is scheduled for a cliff unlock worth $251 million which is the largest among all altcoins this week.
  • SUI, EIGEN, OP, KMNO, ENA, ZORA, and SVL will each unlock tokens valued above $5 million.
  • Solana, Worldcoin, Dogecoin, Avalanche, and others will undergo large linear unlocks during the same period.
  • The total value of all scheduled token unlocks for the week is projected to reach $585 million.
  • Investors are expressing concerns over potential selling pressure as large volumes of altcoins enter circulation.

Multiple altcoins will see token unlocks exceeding $585 million within seven days, potentially impacting market activity and sentiment. Data from Wu Blockchain highlights upcoming cliff and linear unlocks for several projects. Market participants are reacting to the scheduled increases in circulating supply for these altcoins.

HYPE Set for Highest Cliff Unlock

Hyperliquid (HYPE) leads the chart with a projected cliff unlock worth $251 million this week. Cliff unlocks release large token amounts at once, affecting immediate market dynamics. HYPE’s price stands at $25.61, down 56% from its all-time high of $59.

The sharp increase in supply could create temporary price pressures, depending on holder behavior. Some HYPE investors may delay sales due to market conditions or long-term plans. Still, market watchers expect volatility once these altcoins enter circulation.

“HYPE’s unlock size presents higher shock risks due to its sudden nature,” Wu Blockchain noted in its post. Many users on X expressed concerns about possible selloffs from early holders. However, others believe large holders might hold through current lows.

SUI, EIGEN, OP, and Others to Unlock Over $5M

Sui (SUI), EigenCloud (EIGEN), Kamino (KMNO), Optimism (OP), Ethena (ENA), ZORA, and SVL will unlock tokens worth more than $5 million each. These altcoins will expand circulating supply but not all unlocks follow the same pattern. SUI trades at $1.46, while OP stands at $0.28.

EIGEN is priced at $0.39, with KMNO and ENA valued at $0.0531 and $0.21, respectively. These unlocks might pressure their prices based on market liquidity and demand. Each token’s community remains alert for unexpected movements.

Linear unlocks usually have a slower release, reducing potential shock. However, when large volumes are involved, attention remains high. Early investors and contributors hold many of these altcoins under vesting schedules.

ZORA and SVL will also see releases this week with values exceeding the $5 million mark. The unlocked assets belong to insiders such as developers, early backers, or project teams. Wu Blockchain stated that these schedules have existed since the projects’ launch.

Solana, Worldcoin, Dogecoin Among Linear Unlocks

RAIN, Solana (SOL), Trump (TRUMP), Worldcoin (WLD), Dogecoin (DOGE), Avalanche (AVAX), and Aster (ASTER) will see large linear unlocks. These altcoins follow gradual release timelines, easing market absorption. However, market participants still watch unlock trends closely.

SOL currently trades at $125.1, down 57% from its peak of $294. WLD and DOGE are priced at $0.51 and $0.13, respectively. AVAX is at $12.71, while ASTER stands at $0.70.

Linear unlocks continue over time, giving the market room to adapt. Even with gradual releases, traders remain aware of shifting supply dynamics. “Selling pressure could rise if investors choose to exit positions,” said one comment on Wu Blockchain’s post.

The Official Trump token sits at $4.95, while RAIN’s price details remain undisclosed. These altcoins form part of the $585 million expected unlock wave. Their respective price reactions may vary based on broader market behavior.

As of now, the global crypto market cap has dropped by $1.2 trillion since early October. This ongoing decline adds pressure on altcoins facing fresh supply. The total unlock volume for the week stands confirmed at $585 million.

The post Token Unlock Countdown: Will These Altcoins Crash Under Pressure? appeared first on CoinCentral.

Market Opportunity
TokenFi Logo
TokenFi Price(TOKEN)
$0.003979
$0.003979$0.003979
-4.09%
USD
TokenFi (TOKEN) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26